Last reviewed · How we verify
Manufactured Anti-BCMA CAR-T cells
Manufactured Anti-BCMA CAR-T cells is a Biologic drug developed by Thomas Martin, MD. It is currently in Phase 1 development. Also known as: Anti-BCMA CAR-T cells.
At a glance
| Generic name | Manufactured Anti-BCMA CAR-T cells |
|---|---|
| Also known as | Anti-BCMA CAR-T cells |
| Sponsor | Thomas Martin, MD |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma (PHASE1)
- A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia (EARLY_PHASE1)
- UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma (PHASE1)
- Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease (PHASE2)
- Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma (PHASE2)
- P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Manufactured Anti-BCMA CAR-T cells CI brief — competitive landscape report
- Manufactured Anti-BCMA CAR-T cells updates RSS · CI watch RSS
- Thomas Martin, MD portfolio CI
Frequently asked questions about Manufactured Anti-BCMA CAR-T cells
What is Manufactured Anti-BCMA CAR-T cells?
Manufactured Anti-BCMA CAR-T cells is a Biologic drug developed by Thomas Martin, MD.
Who makes Manufactured Anti-BCMA CAR-T cells?
Manufactured Anti-BCMA CAR-T cells is developed by Thomas Martin, MD (see full Thomas Martin, MD pipeline at /company/thomas-martin-md).
Is Manufactured Anti-BCMA CAR-T cells also known as anything else?
Manufactured Anti-BCMA CAR-T cells is also known as Anti-BCMA CAR-T cells.
What development phase is Manufactured Anti-BCMA CAR-T cells in?
Manufactured Anti-BCMA CAR-T cells is in Phase 1.
Related
- Manufacturer: Thomas Martin, MD — full pipeline
- Also known as: Anti-BCMA CAR-T cells
- Compare: Manufactured Anti-BCMA CAR-T cells vs similar drugs
- Pricing: Manufactured Anti-BCMA CAR-T cells cost, discount & access